At Rx Propellant, we aim to fast-track cures for humanity by creating a conducive environment for scientists to excel in their research and development goals. This commitment drives us to transform the life sciences landscape by building dynamic ecosystems that promote innovation, collaboration, and sustainable growth.
India stands at the forefront of life sciences innovation, boasting several powerful clusters of progress. As a global scientific hub, it is poised to become the nexus of innovation, manufacturing, and future advancements, underscored by its dynamic start-up culture, world-class research institutions, and a talent pool globally renowned for its expertise and ingenuity.
A thriving Life Sciences cluster, home to
Rx Propellant’s 7 independent campuses and a community of over 200 global pharmaceutical companies
A specialised ecosystem designed to support every stage of the Life Sciences value chain
A strategically located scenic Life Sciences hub designed to optimise operations and inspire creativity
Whether you are a start-up, an established business, virtual biotech, or an independent researcher, Rx Propellant offers the resources and networks you need to succeed. Together, we can propel the next wave of innovations that will shape the future of healthcare.
We offer state-of-the-art, customizable facilities to meet the unique needs of life sciences research, from Discovery to Delivery.
Turnkey Modular Lab Spaces for Start-ups & Growth Stage Companies
State-of-the-art Lab Spaces for R&D and Light Manufacturing
High-Performance Spaces for Intense Chemistry R&D and Scale-Up
Large-Scale Manufacturing Spaces for Vaccines, Biologics, and Finished Formulations
Built-to-Suit and Dedicated Campuses for Established Life Sciences Enterprises
Integrated Offices and Experience Centers for Elevated Organisational Efficiency
READY TO SCALE? WHAT NEXT? Building a successful Life sciences company takes time, resources, expertise, and persistence. Once a Start-Up achieves significant success in its research and secures initial funding...
Biopharma & medical devices cos view advanced infrastructure t...
CPHI India